Diabetes News Feed

Type 1 Diabetes Prevented, Reversed By Two Cancer Drugs, UCSF Study Shows

Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco. The drugs - imatinib (marketed as Gleevec) and sunitinib (marketed as Sutent) - were found to put type 1 diabetes into remission in 80 percent of the test mice and work permanently in 80 percent of those that go into remission.
Go to Source

Diabetes News Feed

Statement From The American Diabetes Association On Court Ruling To Deny Care To Children With Diabetes

The American Diabetes Association (ADA) is extremely disappointed with the recent California Superior Court ruling striking down a provision of an agreement between the ADA and the California Department of Education that would ensure students with diabetes are safe at school and during school activities. The provision at issue allowed for trained non-licensed school personnel in California to administer insulin when a nurse was not available.
Go to Source

Diabetes News Feed

News From Annals Of Internal Medicine, Nov. 18, 2008, Issue

1. New ACP Guideline Looks at Effectiveness of Drugs Used to Treat Depressive Disorders Second generation treatments for depression are all equally effective according to a new clinical practice guideline from the American College of Physicians (ACP). The guideline is published today in Annals of Internal Medicine, the ACP’s flagship journal.
Go to Source

Diabetes News Feed

Major Diabetes Honor Recognizes Harvard’s Spiegelman; Fellow Award Goes To Junior Investigator At Columbia University Medical Center

Columbia University Medical Center has presented the 2008 Naomi Berrie Awards to a nationally recognized diabetes and obesity researcher, and a promising young investigator, for their outstanding achievements in diabetes research. The Award for Outstanding Achievement in Diabetes Research goes to Bruce Spiegelman, Ph.D., professor of cell biology at the Dana-Farber Cancer Institute/Harvard Medical School in Boston. Dr.
Go to Source

Diabetes News Feed

Researchers Tackle CLL, Diabetes And Trauma-Hemorrhage - Molecular Medicine, A Bi-Monthly Journal

Chronic Lymphocytic Leukemia (CLL) is a disease of the B lymphocytes of the immune system. Under normal conditions, B lymphocytes (or B cells) play an important role in battling infection. CLL is a disease manifested by uncontrolled growth of these B lymphocytes. In this month’s issue of
Go to Source

Diabetes News Feed

Efforts, Grants Seek To Raise Cancer Awareness Among Alaska Natives, Educate Elderly Hispanics On Diabetes Management, Target Infant Mortality

The following is a summary of efforts and grants that seek to reduce racial and ethnic health disparities. Alaska Native Tribal Health Consortium: The
Go to Source

Diabetes News Feed

American Diabetes Association Recognizes World Diabetes Day

The American Diabetes Association will join International Diabetes Federation and their worldwide global diabetes efforts on World Diabetes Day, November 14, to raise awareness of the growing diabetes epidemic. This year’s theme for World Diabetes Day is Diabetes in Children and Adolescents.
Go to Source

Diabetes News Feed

Biodel Reports Protective Effects Of VIAject™ Insulin On Microvascular Function In Patients With Type 2 Diabetes

Biodel Inc. (Nasdaq: BIOD) today reported positive effects of VIAject™ insulin on microvascular function in patients with Type 2 diabetes which were superior to results seen with regular human insulin and insulin lispro. Professor Thomas Forst, MD, Institute for Clinical Research and Development (IKFE), Mainz, Germany, and principal investigator of the study, presented the findings today at the Eighth Annual Diabetes Technology Meeting in Bethesda, MD.
Go to Source

Diabetes News Feed

Why HIV Treatment Makes People So Susceptible To Heart Disease And Diabetes

Clinicians have known for some time that people treated for HIV also become much more susceptible to diabetes and heart disease. A study by scientists at Sydney’s Garvan Institute of Medical Research has now shown some of the reasons why - enabling better patient management and monitoring.
Go to Source

Diabetes News Feed

Company Recalls Syringes Posing Risk to Diabetics

WASHINGTON (Reuters) - U.S. health officials warned doctors and patients on Wednesday that Covidien Ltd was recalling nearly half a million single-use syringes that could pose a serious risk to diabetics.
Go to Source